Navigation Links
Kosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung Cancer
Date:4/14/2008

HAYWARD, Calif., April 14 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated (Nasdaq: KOSN) today announced that the Phase 2 trial of epothilone KOS-1584 in patients with non-small cell lung cancer has been initiated. The Phase 2 trial is an open-label, multi-center, monotherapy study of KOS-1584 in patients with measurable advanced or metastatic non-small cell lung cancer who have previously received only one prior chemotherapy regimen. The primary endpoint of the Phase 2 trial is objective response rate. Secondary endpoints include progression-free survival, time to progression, time to treatment failure, time to response, duration of response and overall survival. KOS-1584 will be administered via a 3-hour intravenous infusion weekly for two weeks out of every three weeks at a dose of 25 mg/m(2). The Phase 2 trial will enroll up to 50 patients in a two-stage Simon design.

"We have been impressed by the breadth and level of activity and tolerability we have observed with KOS-1584 in our Phase 1 trials and believe that KOS-1584 has competitive potential in the emerging epothilone class of anticancer agents," said Helen S. Kim, Kosan's President and Chief Executive Officer. "Kosan's epothilone strategy is to advance KOS-1584 to its next inflection point while seeking a corporate partner to conduct a registration program and advance our preclinical product candidate, KOS-1803, into clinical development. We believe that KOS-1584's therapeutic profile and potential for near-term commercialization enhance its value for potential pharmaceutical collaborators."

KOS-1584 is a member of a class of cytotoxic macrolides (epothilones) capable of causing mitotic arrest by polymerization of cellular microtubules. Since microtubules
'/>"/>

SOURCE Kosan Biosciences Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Kosan Initiates Phase 2 Trial of Alvespimycin, Second-Generation Hsp90 Inhibitor, in HER2-Positive Metastatic Breast Cancer
2. Kosan Presents Updated Data on Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma at Ash
3. Kosan Presents Phase 1 Data Showing Antitumor Activity and Safety Profile of Epothilone KOS-1584 at AACR/NCI/EORTC Meeting
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
6. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
7. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
8. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
9. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
10. Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
11. Metabolex Initiates Phase 1 Trial of MBX-2982

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...PRNewswire-FirstCall/ -- Escalon Medical Corp. (Na...iscal first quarter ended September 30, 2009. ,...revenue decreased approximately $234,000, or 2.7%,... September 30, 2009 as compared to the same period...ased net revenue of $8,434,000 compared with $8,66...
(Date:11/20/2009)... Unilens Vision Inc. (OTC..., which develops, licenses, manufactures, distribu...ported its operating results for the first quarter...s excluding royalty income, were $1,683,673 in the...eported in the previous year first quarter (FY2009...
(Date:11/20/2009)...ov. 20 The National Association of...ced a new initiative in the war on methamphetamine...a multi-state electronic tracking program that enf...C) medicines containing pseudoephedrine in real-ti... is based on a system that was developed and teste...
Breaking Medicine Technology:Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7Unilens Vision Reports Record First Quarter Earnings and Royalty Income 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 4National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 2National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 3Journal of Midwifery 26amp 3B Womens Health honors outstanding authors 54619 1Journal of Midwifery 26amp 3B Womens Health honors outstanding authors 54619 2Imagenetix Inc Announces Interview With Bloomberg Radio 13589 1Imagenetix Inc Announces Interview With Bloomberg Radio 13589 2Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 1Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 2Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 3Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 4
...gentina, May 21 Today at the,World Congress of Ca...,Perspectives in Atrial Fibrillation Management" c...gy, St George,s University of London,highlighted t...al trial,results, as the way forward in the future...n form of cardiac arrhythmia., To view the Multim...
...gnificant Reduction of IBS Pain and Normalizing Mo... SAN DIEGO, May 20 Tioga Pharmaceuticals, Inc. t...udy of its oral kappa opioid,receptor agonist, asi...cant,results in the treatment of Irritable Bowel S...provement in diarrhea-predominant (D-IBS) and,alte...
Other Medicine Technology:ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 2ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 3ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 4ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 5ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress 6Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 2Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 3Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 4
(Date:11/21/2009)...l apparel company launches men,s lab coats at Medi...Clemente, Calif. (PRWEB) November 21, 2009 -- Mede...today announced the launch of its men,s lab coats,...ternational trade fair for the medical industry he...s men,s collection with three varying lab coat sty...
(Date:11/21/2009)...Group merges their practice with that of E. Steven... (PRWEB) November 21, 2009 -- The New Hav...ibson, Dr. Dean Cloutier, Dr. John Plachtyna and D...practice with that of esteemed colleague Dr. E. St...ed to retire from dentistry in order to concentrat...
(Date:11/20/2009)...ire-FirstCall/ - NUCRYST Pharmaceuticals Corp. ann...s will be held on Monday, December 21, 2009. The p...wo special resolutions. The first special resoluti...substantially all of the assets of NUCRYST, substa...chase agreement dated November 10, 2009 among the ...
(Date:11/20/2009)...re/ -- Following a recall by Unilever The Stop &am...d,s Country Crock ® Side Dishes DELUXE Chedda...ide Dishes DELUXE Four Cheese Pasta due to an unde... dates and UPCs are affected: ,, Shedd,s Count...i Rice 21 oz, UPC 027400218316, Best By NOV 29 09 ...
(Date:11/20/2009)...ewswire/ -- The American Dental Association (ADA) ...(FDA) to establish appropriate classifications for...about the safety of whitening products that are of...al consultation or examination by a dentist, the A... based tooth whitening or bleaching agents can har...
Breaking Medicine News(10 mins):Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:New Haven Dental Group Expands Their Vision 2Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2
...ion with its obsession of MP3 players that blare o...of going deaf than the previous generation.// Rese... 14 to 16 year olds use their MP3 players for a mi...stening to loud music. 28 percent of those polled ...
...ty Executive (HSE) says that recycling boxes are u...o lift them. In a new report, the HSE// said that .... The containers, which are used by countless hous...t. The report, which was compiled after a three-mo...
...vestigations conducted by the General of Health De...d positive for containing harmful drugs in erectil...ines. After routine investigations Medsafe ide...uld also interfere with some heart medications. ...
...leases a dose of nicotine and is one of the import...king.// The federal government has announced t.... The lozenges are to join nicotine patches, gums ...rict the availability of a safe and effective smok...
...ate has risen since the government sang from the "...song sheet and began paying out 3,000 Australian//... released Monday showed. But Treasurer Peter...ity rate that is the bane of Australia - and most ...
...ting programme for notifiable avian influenza has ...meat industry is free of the disease according// t...Michael Brooks. The testing programme has tes...s from thousands of poultry meat birds. There...
Other Medicine News:Health News:Australia's Baby Bonus Plan has Increased the Birth Rate 2
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
Medicine Products: